Solvent/detergent treatment of platelet concentrates enhances the release of growth factors

Transfusion

Volumn 48, Issue 6, 2008, Pages 1090-1098

  Burnouf, Thierry ^b   Tseng, Yu H ^b   Kuo, Ya P ^b   Su, Chen Y ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; DETERGENT; EPIDERMAL GROWTH FACTOR; OCTOXINOL; PLATELET DERIVED GROWTH FACTOR AB; SOLVENT; SOMATOMEDIN C; THROMBIN; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA1; TRIBUTYL PHOSPHATE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR STABILITY; PROTEIN SECRETION; THROMBOCYTE; THROMBOCYTOPHERESIS; UPREGULATION; VIRUS INACTIVATION;

ANIMALS; BLOOD PLATELETS; CATTLE; CELL COUNT; CELL SEPARATION; DETERGENTS; ENZYME ACTIVATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OCTOXYNOL; PHOSPHORIC ACID ESTERS; SOLVENTS; THROMBIN;

EID: 44849116928     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01691.x     Document Type: Article

References (37)

1. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004 62 : 489 96.
2. Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 2006 38 : 174 87.
3. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997 55 : 1294 9.
4. Oyama T, Nishimoto S, Tsugawa T, Shimizu F. Efficacy of platelet-rich plasma in alveolar bone grafting. J Oral Maxillofac Surg 2004 62 : 555 8.
5. Green DM, Klink B. Platelet gel as an intraoperatively procured platelet-based alternative to fibrin glue. Plast Reconstr Surg 1998 101 : 1161 2.
6. Velich N, Nemeth Z, Hrabak K, Suba Z, Szabo G. Repair of bony defect with combination biomaterials. J Craniofac Surg 2004 15 : 11 5.
7. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004 44 : 1013 8.
8. Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 2002 18 : 27 33.
9. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004 91 : 4 15.
10. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003 24 : 3095 100.
11. Borzini P, Mazzucco L. Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point? ISBT Sci Ser 2007 2 : 272 81.
12. Kubota S, Kawata K, Yanagita T, Doi H, Kitoh T, Takigawa M. Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem (Tokyo) 2004 136 : 279 82.
13. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 85 : 638 46.
14. Borzini P, Mazzucco L. Platelet gels and releasates. Curr Opin Hematol 2005 12 : 473 9.
15. Schliephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002 31 : 469 84.
16. Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006 14 : 403 12.
17. Valbonesi M, Giannini G, Migliori F, Dalla Costa R, Galli A. The role of autologous fibrin-platelet glue in plastic surgery: a preliminary report. Int J Artif Organs 2002 25 : 334 8.
18. Zimmermann R, Arnold D, Strasser E, Ringwald J, Schlegel A, Wiltfang J, Eckstein R. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 2003 85 : 283 9.
19. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, Eckstein R. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001 41 : 1217 24.
20. Snyder EL, Calhoun BC. Topical platelet growth factor therapy: of lotions and potions. Transfusion 2001 41 : 1186 9.
21. Smrke D, Gubina B, Domanovic D, Rozman P. Allogeneic platelet gel with autologous cancellous bone graft for the treatment of a large bone defect. Eur Surg Res 2007 39 : 170 4.
22. Chen TM, Tsai JC, Burnouf T. Cranioplasty using osteoconductive scaffold and platelet glue. J Trauma (in press).
23. Perseghin P, Sciorelli G, Belotti D, Speranza T, Pogliani EM, Ferro O, Gianoli M, Porta F, Paolini G. Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds. Transfusion 2005 45 : 1544 6.
24. Bryant BJ, Klein HG. Pathogen inactivation: the definitive safeguard for the blood supply. Arch Pathol Lab Med 2007 131 : 719 33.
25. Klein HG. Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005 257 : 224 37.
26. McCullough J. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections. Am J Clin Pathol 2007 128 : 945 55.
27. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007 47 : 2338 47.
28. Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system. Transfusion 2006 46 : 2100 8.
29. Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system. Vox Sang 2006 91 : 56 62.
30. Su CY, Chiang CC, Lai WF, Lin KW, Burnouf T. Platelet-derived growth factor-AB and transforming growth factor-beta1 in platelet gels activated by single-donor human thrombin. Transfusion 2004 44 : 945.
31. WHO. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. Geneva : WHO 2003. p. 1 72. Available from: http://www.WHO.int
32. Tabor E. The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. Transfusion 1999 39 : 1160 8.
33. Burnouf T, Radosevich M. Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 2000 14 : 94 110.
34. Karey KP, Sirbasku DA. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the alpha-granule and release in response to thrombin. Blood 1989 74 : 1093 100.
35. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004 14 : 337 75.
36. Bowen-Pope DF, Malpass TW, Foster DM, Ross R. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. Blood 1984 64 : 458 69.
37. Horowitz B, Minor P, Morgenthaler JJ, Burnouf T, McIntosh R, Padilla A, Thorpe R, van Aken WG. WHO Expert Committee on biological standardization. World Health Organ Tech Rep Ser 2004 924 : 1 232, backcover.